...
首页> 外文期刊>Journal of medicinal food >Modifying effects of lemongrass essential oil on specific tissue response to the carcinogen N-Methyl-N-nitrosurea in female BALB/c mice
【24h】

Modifying effects of lemongrass essential oil on specific tissue response to the carcinogen N-Methyl-N-nitrosurea in female BALB/c mice

机译:柠檬草精油对雌性BALB / c小鼠对致癌物N-甲基-N-硝基脲的特定组织反应的修饰作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Lemongrass (Cymbopogon citratus Stapf) essential oil has been used worldwide because of its ethnobotanical and medicinal usefulness. Regarding its medicinal usefulness, the present study evaluated the beneficial effects of lemongrass essential oil (LGEO) oral treatment on cell proliferation and apoptosis events and on early development of hyperplastic lesions in the mammary gland, colon, and urinary bladder induced by N-methyl-N-nitrosourea (MNU) in female BALB/c mice. The animals were allocated into three groups: G1, treated with LGEO vehicle for 5 weeks (five times per week); G2, treated with LGEO vehicle as for G1 and MNU (two injections each of 30 mg/kg of body weight at weeks 3 and 5); and G3, treated with LGEO (five times each with 500 mg/kg of body weight per week) and MNU as for G2. Twenty-four hours after the last MNU application, all animals were euthanized, and mammary glands, colon, and urinary bladder were collected for histological and immunohistochemical analysis. LGEO oral treatment significantly changed the indexes of apoptosis and/or cellular proliferation for the tissues analyzed. In particular, the treatment reduced the incidence of hyperplastic lesions and increased apoptosis in mammary epithelial cells. This increment in the apoptosis response may be related to a favorable balance in Bcl-2/Bax immunoreactivity in mammary epithelial cells. These findings indicate that LGEO presented a protective role against early MNU-induced mammary gland alterations in BALB/c mice.
机译:柠檬草(Cymbopogon citratus Stapf)精油因其在植物学和医学上的实用性而在世界范围内使用。关于其药用价值,本研究评估了柠檬草精油(LGEO)口服治疗对细胞增殖和凋亡事件以及N-甲基-甲基苯丙胺诱导的乳腺,结肠和膀胱增生性病变早期发展的有益作用。雌性BALB / c小鼠中的N-亚硝基脲(MNU)。将动物分为三组:G1,用LGEO载体处理5周(每周5次); G2,与G1和MNU一样,用LGEO载体处理(在第3和第5周分别以30 mg / kg体重进行两次注射);和G3,与LG2一样,用LGEO(每次五次,每周500毫克/千克体重)和MNU处理。最后一次使用MNU后24小时,所有动物均被安乐死,并收集乳腺,结肠和膀胱进行组织学和免疫组化分析。 LGEO口服治疗显着改变了所分析组织的凋亡和/或细胞增殖指标。特别地,该治疗降低了乳腺上皮细胞增生性病变的发生率并增加了细胞凋亡。凋亡反应的这种增加可能与乳腺上皮细胞中Bcl-2 / Bax免疫反应性的良好平衡有关。这些发现表明,LGEO对BALB / c小鼠的早期MNU诱导的乳腺改变具有保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号